Home » Topics » BioWorld Science

BioWorld Science
RSS

DNDi receives financial support development of drugs for sleeping sickness and river blindness

Nov. 27, 2019

There's an app for that?!: web-based tool facilitates new antibiotic development

Nov. 27, 2019

Activated NK-92 cell regimens show activity in Merkel cell carcinoma trial

Nov. 27, 2019

La Jolla re-evaluates its development of LJPC-401 due to mixed clinical results

Nov. 27, 2019

FDA approves advancement of Plenitude study with PPP-001

Nov. 27, 2019

Lipids and lupus

Nov. 27, 2019

Less can be more for HIV vaccines, in several ways

Nov. 27, 2019

FDA grants accelerated approval to Oxbryta for sickle cell disease

Nov. 26, 2019

Enrollment underway in ImmunoGen's phase I/II study of IMGN-632 in AML

Nov. 26, 2019

Poxel reports topline data from TIMES 3 open-label extension of imeglimin in type 2 diabetes

Nov. 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...